nodes	percent_of_prediction	percent_of_DWPC	metapath
Cisapride—CYP2A6—Fluorouracil—head and neck cancer	0.171	0.196	CbGbCtD
Cisapride—CYP2D6—Hydroxyurea—head and neck cancer	0.141	0.161	CbGbCtD
Cisapride—CYP3A7—Docetaxel—head and neck cancer	0.0891	0.102	CbGbCtD
Cisapride—CYP3A7-CYP3A51P—Docetaxel—head and neck cancer	0.0891	0.102	CbGbCtD
Cisapride—CYP2C8—Fluorouracil—head and neck cancer	0.0842	0.0965	CbGbCtD
Cisapride—CYP3A5—Docetaxel—head and neck cancer	0.0669	0.0767	CbGbCtD
Cisapride—CYP1A2—Fluorouracil—head and neck cancer	0.0652	0.0747	CbGbCtD
Cisapride—CYP2C9—Fluorouracil—head and neck cancer	0.0587	0.0673	CbGbCtD
Cisapride—CYP2D6—Vinblastine—head and neck cancer	0.0497	0.057	CbGbCtD
Cisapride—CYP3A4—Vinblastine—head and neck cancer	0.0316	0.0363	CbGbCtD
Cisapride—CYP3A4—Docetaxel—head and neck cancer	0.0261	0.0299	CbGbCtD
Cisapride—Gefitinib—EGFR—head and neck cancer	0.00426	0.636	CrCbGaD
Cisapride—Gefitinib—CYP1A1—head and neck cancer	0.00244	0.364	CrCbGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—YAP1—head and neck cancer	6.64e-05	0.000547	CbGpPWpGaD
Cisapride—HTR2A—G alpha (q) signalling events—PIK3CA—head and neck cancer	6.63e-05	0.000546	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—UROD—head and neck cancer	6.61e-05	0.000544	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—GRP—head and neck cancer	6.6e-05	0.000544	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—DPYD—head and neck cancer	6.56e-05	0.00054	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT6—head and neck cancer	6.41e-05	0.000528	CbGpPWpGaD
Cisapride—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	6.32e-05	0.00052	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—PIK3CA—head and neck cancer	6.24e-05	0.000514	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—YAP1—head and neck cancer	6.23e-05	0.000513	CbGpPWpGaD
Cisapride—DRD2—Circadian rythm related genes—TP53—head and neck cancer	6.15e-05	0.000507	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—NAT2—head and neck cancer	6.04e-05	0.000497	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—PIK3CA—head and neck cancer	5.93e-05	0.000488	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—NAT2—head and neck cancer	5.9e-05	0.000486	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—GRP—head and neck cancer	5.82e-05	0.00048	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—HRAS—head and neck cancer	5.77e-05	0.000476	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—GRP—head and neck cancer	5.73e-05	0.000472	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—YAP1—head and neck cancer	5.67e-05	0.000467	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT6—head and neck cancer	5.65e-05	0.000466	CbGpPWpGaD
Cisapride—HTR4—GPCR downstream signaling—AKT1—head and neck cancer	5.61e-05	0.000462	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT6—head and neck cancer	5.56e-05	0.000458	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—IL2—head and neck cancer	5.55e-05	0.000457	CbGpPWpGaD
Cisapride—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—head and neck cancer	5.49e-05	0.000452	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	5.43e-05	0.000447	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—CCND1—head and neck cancer	5.41e-05	0.000446	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	5.37e-05	0.000442	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—DPYD—head and neck cancer	5.29e-05	0.000436	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—PTEN—head and neck cancer	5.23e-05	0.00043	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—DPYD—head and neck cancer	5.17e-05	0.000426	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—NAT2—head and neck cancer	5.11e-05	0.000421	CbGpPWpGaD
Cisapride—HTR4—Signaling by GPCR—AKT1—head and neck cancer	5.1e-05	0.00042	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—YAP1—head and neck cancer	5.02e-05	0.000414	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—YAP1—head and neck cancer	5e-05	0.000412	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—YAP1—head and neck cancer	4.92e-05	0.000405	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—YAP1—head and neck cancer	4.91e-05	0.000404	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.84e-05	0.000399	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.8e-05	0.000395	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—VEGFA—head and neck cancer	4.72e-05	0.000389	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—STAT3—head and neck cancer	4.67e-05	0.000385	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—NAT2—head and neck cancer	4.56e-05	0.000376	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—DPYD—head and neck cancer	4.48e-05	0.000369	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MAPK3—head and neck cancer	4.47e-05	0.000368	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	4.42e-05	0.000364	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	4.37e-05	0.00036	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—YAP1—head and neck cancer	4.25e-05	0.00035	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—MAPK1—head and neck cancer	4.25e-05	0.00035	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—EGFR—head and neck cancer	4.25e-05	0.00035	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—NAT2—head and neck cancer	4.2e-05	0.000346	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—NAT2—head and neck cancer	4.16e-05	0.000343	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—TYMS—head and neck cancer	4.08e-05	0.000336	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—IL2—head and neck cancer	4.06e-05	0.000335	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GSTM1—head and neck cancer	4.03e-05	0.000332	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—DPYD—head and neck cancer	4e-05	0.000329	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—GPX1—head and neck cancer	3.86e-05	0.000318	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—CYP1A1—head and neck cancer	3.82e-05	0.000315	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—YAP1—head and neck cancer	3.8e-05	0.000313	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	3.77e-05	0.000311	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—TYMS—head and neck cancer	3.74e-05	0.000308	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	3.74e-05	0.000308	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GSTM1—head and neck cancer	3.69e-05	0.000304	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—IL2—head and neck cancer	3.69e-05	0.000304	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—PIK3CA—head and neck cancer	3.69e-05	0.000304	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—DPYD—head and neck cancer	3.68e-05	0.000303	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—DPYD—head and neck cancer	3.65e-05	0.0003	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—TP53—head and neck cancer	3.57e-05	0.000294	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—NAT2—head and neck cancer	3.55e-05	0.000293	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—GPX1—head and neck cancer	3.54e-05	0.000291	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—CYP1A1—head and neck cancer	3.5e-05	0.000288	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—YAP1—head and neck cancer	3.49e-05	0.000287	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—YAP1—head and neck cancer	3.46e-05	0.000285	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—HRAS—head and neck cancer	3.41e-05	0.000281	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—IL2—head and neck cancer	3.28e-05	0.00027	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	3.19e-05	0.000263	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—NOTCH1—head and neck cancer	3.17e-05	0.000261	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—DPYD—head and neck cancer	3.12e-05	0.000257	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—TYMS—head and neck cancer	3.02e-05	0.000248	CbGpPWpGaD
Cisapride—HTR4—Signaling Pathways—AKT1—head and neck cancer	3.01e-05	0.000248	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GSTM1—head and neck cancer	2.98e-05	0.000246	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—IL2—head and neck cancer	2.98e-05	0.000245	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—MAPK3—head and neck cancer	2.97e-05	0.000244	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—YAP1—head and neck cancer	2.96e-05	0.000244	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—TYMS—head and neck cancer	2.95e-05	0.000243	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GSTM1—head and neck cancer	2.91e-05	0.00024	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—IL2—head and neck cancer	2.89e-05	0.000238	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—GPX1—head and neck cancer	2.85e-05	0.000235	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.85e-05	0.000235	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—IL2—head and neck cancer	2.85e-05	0.000234	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—CYP1A1—head and neck cancer	2.83e-05	0.000233	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—MAPK1—head and neck cancer	2.82e-05	0.000232	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—EGFR—head and neck cancer	2.82e-05	0.000232	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—GPX1—head and neck cancer	2.79e-05	0.00023	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.79e-05	0.000229	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—CYP1A1—head and neck cancer	2.76e-05	0.000227	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—NAT2—head and neck cancer	2.74e-05	0.000226	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—PIK3CA—head and neck cancer	2.7e-05	0.000222	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—IL2—head and neck cancer	2.63e-05	0.000216	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.6e-05	0.000214	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—IL2—head and neck cancer	2.59e-05	0.000213	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—NOTCH1—head and neck cancer	2.56e-05	0.00021	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—TYMS—head and neck cancer	2.55e-05	0.00021	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GSTM1—head and neck cancer	2.52e-05	0.000208	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.49e-05	0.000205	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—PIK3CA—head and neck cancer	2.45e-05	0.000202	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—GPX1—head and neck cancer	2.42e-05	0.000199	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—DPYD—head and neck cancer	2.41e-05	0.000198	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK3—head and neck cancer	2.39e-05	0.000197	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—CYP1A1—head and neck cancer	2.39e-05	0.000197	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—YAP1—head and neck cancer	2.28e-05	0.000188	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—TYMS—head and neck cancer	2.28e-05	0.000188	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—MAPK1—head and neck cancer	2.28e-05	0.000188	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—EGFR—head and neck cancer	2.28e-05	0.000188	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTGS2—head and neck cancer	2.27e-05	0.000187	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	2.27e-05	0.000187	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—HRAS—head and neck cancer	2.27e-05	0.000187	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—NOTCH1—head and neck cancer	2.26e-05	0.000186	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GSTM1—head and neck cancer	2.25e-05	0.000186	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	2.22e-05	0.000183	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—NOTCH1—head and neck cancer	2.22e-05	0.000183	CbGpPWpGaD
Cisapride—HTR2B—GPCR downstream signaling—AKT1—head and neck cancer	2.2e-05	0.000181	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—IL2—head and neck cancer	2.18e-05	0.00018	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—PIK3CA—head and neck cancer	2.18e-05	0.000179	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—GPX1—head and neck cancer	2.16e-05	0.000178	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—CYP1A1—head and neck cancer	2.14e-05	0.000176	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—CCND1—head and neck cancer	2.12e-05	0.000175	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK3—head and neck cancer	2.11e-05	0.000174	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—TYMS—head and neck cancer	2.1e-05	0.000173	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTGS2—head and neck cancer	2.08e-05	0.000172	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK3—head and neck cancer	2.08e-05	0.000171	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—TYMS—head and neck cancer	2.08e-05	0.000171	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GSTM1—head and neck cancer	2.07e-05	0.000171	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GSTM1—head and neck cancer	2.05e-05	0.000169	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PTEN—head and neck cancer	2.05e-05	0.000169	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—MAPK1—head and neck cancer	2.01e-05	0.000166	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—EGFR—head and neck cancer	2.01e-05	0.000165	CbGpPWpGaD
Cisapride—HTR2B—Signaling by GPCR—AKT1—head and neck cancer	2e-05	0.000165	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—GPX1—head and neck cancer	1.98e-05	0.000163	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PTEN—head and neck cancer	1.98e-05	0.000163	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—MAPK1—head and neck cancer	1.98e-05	0.000163	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—EGFR—head and neck cancer	1.98e-05	0.000163	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—PIK3CA—head and neck cancer	1.98e-05	0.000163	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—GPX1—head and neck cancer	1.97e-05	0.000162	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.97e-05	0.000162	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—CYP1A1—head and neck cancer	1.96e-05	0.000162	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—CYP1A1—head and neck cancer	1.95e-05	0.00016	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.94e-05	0.00016	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—PIK3CA—head and neck cancer	1.92e-05	0.000158	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—PIK3CA—head and neck cancer	1.89e-05	0.000156	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—VEGFA—head and neck cancer	1.85e-05	0.000153	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—STAT3—head and neck cancer	1.83e-05	0.000151	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—HRAS—head and neck cancer	1.83e-05	0.000151	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PTEN—head and neck cancer	1.82e-05	0.00015	CbGpPWpGaD
Cisapride—HTR2C—GPCR downstream signaling—AKT1—head and neck cancer	1.78e-05	0.000146	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—TYMS—head and neck cancer	1.78e-05	0.000146	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—IL2—head and neck cancer	1.76e-05	0.000145	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GSTM1—head and neck cancer	1.76e-05	0.000145	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.75e-05	0.000144	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK3—head and neck cancer	1.75e-05	0.000144	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—PIK3CA—head and neck cancer	1.74e-05	0.000144	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—PIK3CA—head and neck cancer	1.72e-05	0.000141	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—CCND1—head and neck cancer	1.71e-05	0.000141	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—GPX1—head and neck cancer	1.68e-05	0.000138	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTGS2—head and neck cancer	1.68e-05	0.000138	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—MAPK1—head and neck cancer	1.67e-05	0.000137	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—EGFR—head and neck cancer	1.67e-05	0.000137	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—CYP1A1—head and neck cancer	1.66e-05	0.000137	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PTEN—head and neck cancer	1.65e-05	0.000136	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTGS2—head and neck cancer	1.64e-05	0.000135	CbGpPWpGaD
Cisapride—HTR2C—Signaling by GPCR—AKT1—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—HRAS—head and neck cancer	1.61e-05	0.000133	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.6e-05	0.000132	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—HRAS—head and neck cancer	1.59e-05	0.000131	CbGpPWpGaD
Cisapride—DRD2—GPCR downstream signaling—AKT1—head and neck cancer	1.57e-05	0.000129	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—IL2—head and neck cancer	1.55e-05	0.000128	CbGpPWpGaD
Cisapride—HTR2A—GPCR downstream signaling—AKT1—head and neck cancer	1.54e-05	0.000127	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—IL2—head and neck cancer	1.53e-05	0.000126	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—CCND1—head and neck cancer	1.51e-05	0.000125	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—VEGFA—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—CCND1—head and neck cancer	1.49e-05	0.000123	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—STAT3—head and neck cancer	1.48e-05	0.000122	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PTEN—head and neck cancer	1.47e-05	0.000121	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PTEN—head and neck cancer	1.46e-05	0.00012	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—PIK3CA—head and neck cancer	1.45e-05	0.000119	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PTEN—head and neck cancer	1.44e-05	0.000118	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PTEN—head and neck cancer	1.43e-05	0.000118	CbGpPWpGaD
Cisapride—DRD2—Signaling by GPCR—AKT1—head and neck cancer	1.42e-05	0.000117	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTGS2—head and neck cancer	1.42e-05	0.000117	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK3—head and neck cancer	1.41e-05	0.000116	CbGpPWpGaD
Cisapride—HTR2A—Signaling by GPCR—AKT1—head and neck cancer	1.4e-05	0.000115	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—TP53—head and neck cancer	1.4e-05	0.000115	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—PIK3CA—head and neck cancer	1.4e-05	0.000115	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—TYMS—head and neck cancer	1.37e-05	0.000113	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.37e-05	0.000113	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GSTM1—head and neck cancer	1.35e-05	0.000112	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—MAPK1—head and neck cancer	1.35e-05	0.000111	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—EGFR—head and neck cancer	1.34e-05	0.000111	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—HRAS—head and neck cancer	1.34e-05	0.00011	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—VEGFA—head and neck cancer	1.32e-05	0.000109	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—STAT3—head and neck cancer	1.31e-05	0.000108	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—VEGFA—head and neck cancer	1.3e-05	0.000107	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—GPX1—head and neck cancer	1.3e-05	0.000107	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—STAT3—head and neck cancer	1.29e-05	0.000106	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—CYP1A1—head and neck cancer	1.28e-05	0.000106	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—PIK3CA—head and neck cancer	1.28e-05	0.000106	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTGS2—head and neck cancer	1.27e-05	0.000105	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK3—head and neck cancer	1.25e-05	0.000103	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PTEN—head and neck cancer	1.24e-05	0.000102	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK3—head and neck cancer	1.23e-05	0.000101	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—MAPK1—head and neck cancer	1.19e-05	9.78e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—EGFR—head and neck cancer	1.19e-05	9.78e-05	CbGpPWpGaD
Cisapride—HTR2B—Signaling Pathways—AKT1—head and neck cancer	1.18e-05	9.73e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—MAPK1—head and neck cancer	1.17e-05	9.62e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTGS2—head and neck cancer	1.17e-05	9.62e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—EGFR—head and neck cancer	1.17e-05	9.62e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—PIK3CA—head and neck cancer	1.17e-05	9.61e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTGS2—head and neck cancer	1.16e-05	9.54e-05	CbGpPWpGaD
Cisapride—CYP3A7—Metabolism—AKT1—head and neck cancer	1.14e-05	9.41e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—TP53—head and neck cancer	1.13e-05	9.3e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PTEN—head and neck cancer	1.11e-05	9.12e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—HRAS—head and neck cancer	1.08e-05	8.89e-05	CbGpPWpGaD
Cisapride—CYP2A6—Metabolism—AKT1—head and neck cancer	1.05e-05	8.62e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—PIK3CA—head and neck cancer	1.03e-05	8.52e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—PIK3CA—head and neck cancer	1.03e-05	8.48e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PTEN—head and neck cancer	1.02e-05	8.39e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—PIK3CA—head and neck cancer	1.01e-05	8.35e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—PIK3CA—head and neck cancer	1.01e-05	8.32e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PTEN—head and neck cancer	1.01e-05	8.32e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—TP53—head and neck cancer	9.97e-06	8.21e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTGS2—head and neck cancer	9.9e-06	8.15e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—TP53—head and neck cancer	9.81e-06	8.08e-05	CbGpPWpGaD
Cisapride—HTR2C—Signaling Pathways—AKT1—head and neck cancer	9.54e-06	7.85e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—HRAS—head and neck cancer	9.53e-06	7.85e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—HRAS—head and neck cancer	9.38e-06	7.72e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—PIK3CA—head and neck cancer	8.75e-06	7.21e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PTEN—head and neck cancer	8.63e-06	7.11e-05	CbGpPWpGaD
Cisapride—CYP2B6—Metabolism—AKT1—head and neck cancer	8.45e-06	6.96e-05	CbGpPWpGaD
Cisapride—DRD2—Signaling Pathways—AKT1—head and neck cancer	8.42e-06	6.93e-05	CbGpPWpGaD
Cisapride—HTR2A—Signaling Pathways—AKT1—head and neck cancer	8.28e-06	6.82e-05	CbGpPWpGaD
Cisapride—CYP3A5—Metabolism—AKT1—head and neck cancer	8.26e-06	6.8e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—PIK3CA—head and neck cancer	7.81e-06	6.44e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTGS2—head and neck cancer	7.64e-06	6.29e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—PIK3CA—head and neck cancer	7.19e-06	5.92e-05	CbGpPWpGaD
Cisapride—CYP2C8—Metabolism—AKT1—head and neck cancer	7.15e-06	5.89e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—PIK3CA—head and neck cancer	7.12e-06	5.87e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PTEN—head and neck cancer	6.66e-06	5.49e-05	CbGpPWpGaD
Cisapride—CYP2C19—Metabolism—AKT1—head and neck cancer	6.38e-06	5.26e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—PIK3CA—head and neck cancer	6.09e-06	5.01e-05	CbGpPWpGaD
Cisapride—CYP2D6—Metabolism—AKT1—head and neck cancer	5.87e-06	4.84e-05	CbGpPWpGaD
Cisapride—CYP2C9—Metabolism—AKT1—head and neck cancer	5.82e-06	4.79e-05	CbGpPWpGaD
Cisapride—CYP1A2—Metabolism—AKT1—head and neck cancer	4.97e-06	4.1e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—PIK3CA—head and neck cancer	4.7e-06	3.87e-05	CbGpPWpGaD
Cisapride—CYP3A4—Metabolism—AKT1—head and neck cancer	3.84e-06	3.16e-05	CbGpPWpGaD
